Richard Aspinall

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study

Eleonora Scorletti, Lokpal Bhatia, Keith McCormick et al. · Hepatology · 2014 · 310 citations

Medicine, Nutritional Sciences, Pharmacology +17

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension

Dhiraj Tripathi, Adrian J. Stanley, Peter Hayes et al. · Gut · 2020 · 310 citations · Full text

Medicine, Radiology, Gastroenterology +11

Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease

Eleonora Scorletti, Paul R. Afolabi, Elizabeth A. Miles et al. · Gastroenterology · 2020 · 221 citations · Full text

Life Sciences, Microbiology, Microbial Ecology +14

Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study

Gideon M. Hirschfield, Mitchell L. Shiffman, Aliya Gulamhusein et al. · Hepatology · 2023 · 113 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials

Jason Grebely, Gregory J. Dore, Stefan Zeuzem et al. · Clinical Infectious Diseases · 2016 · 92 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +12